231 related articles for article (PubMed ID: 21034635)
21. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
[TBL] [Abstract][Full Text] [Related]
22. The results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone (Tokyo P3R): a multicenter, randomized, phase II, non-placebo-controlled trial.
Tsujino T; Isayama H; Nakai Y; Ito Y; Togawa O; Toda N; Arizumi T; Kogure H; Yamamoto K; Mizuno S; Yashima Y; Yagioka H; Sasaki T; Matsubara S; Yamamoto N; Hirano K; Sasahira N; Tada M; Koike K
J Gastroenterol; 2013 Aug; 48(8):982-8. PubMed ID: 23090004
[TBL] [Abstract][Full Text] [Related]
23. Nafamostat mesilate for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis based on prospective, randomized, and controlled trials.
Xie Y; Cheng Z; Deng C; Deng M; Zhang H
Medicine (Baltimore); 2023 Oct; 102(41):e35174. PubMed ID: 37832051
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
25. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic effect of somatostatin in preventing Post-ERCP pancreatitis: an updated meta-analysis.
Qin X; Lei WS; Xing ZX; Shi F
Saudi J Gastroenterol; 2015; 21(6):372-8. PubMed ID: 26655132
[TBL] [Abstract][Full Text] [Related]
27. Glyceryl trinitrate for prevention of post-ERCP pancreatitis and improve the rate of cannulation: a meta-analysis of prospective, randomized, controlled trials.
Ding J; Jin X; Pan Y; Liu S; Li Y
PLoS One; 2013; 8(10):e75645. PubMed ID: 24098392
[TBL] [Abstract][Full Text] [Related]
28. Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials.
Yang C; Zhao Y; Li W; Zhu S; Yang H; Zhang Y; Liu X; Peng N; Fan P; Jin X
Pancreatology; 2017; 17(5):681-688. PubMed ID: 28734720
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
Andriulli A; Leandro G; Niro G; Mangia A; Festa V; Gambassi G; Villani MR; Facciorusso D; Conoscitore P; Spirito F; De Maio G
Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786
[TBL] [Abstract][Full Text] [Related]
30. Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
Tsujino T; Komatsu Y; Isayama H; Hirano K; Sasahira N; Yamamoto N; Toda N; Ito Y; Nakai Y; Tada M; Matsumura M; Yoshida H; Kawabe T; Shiratori Y; Omata M
Clin Gastroenterol Hepatol; 2005 Apr; 3(4):376-83. PubMed ID: 15822043
[TBL] [Abstract][Full Text] [Related]
31. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis.
Ding X; Chen M; Huang S; Zhang S; Zou X
Gastrointest Endosc; 2012 Dec; 76(6):1152-9. PubMed ID: 23164513
[TBL] [Abstract][Full Text] [Related]
32. Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis.
Li S; Cao G; Chen X; Wu T
Eur J Gastroenterol Hepatol; 2012 May; 24(5):477-81. PubMed ID: 22293331
[TBL] [Abstract][Full Text] [Related]
33. Aggressive Hydration With Lactated Ringer Solution in Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-analysis of Randomized Controlled Trials.
Zhang ZF; Duan ZJ; Wang LX; Zhao G; Deng WG
J Clin Gastroenterol; 2017 Mar; 51(3):e17-e26. PubMed ID: 28178088
[TBL] [Abstract][Full Text] [Related]
34. Comparative Efficacy of 9 Major Drugs for Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Network Meta-Analysis.
Lyu Y; Wang B; Cheng Y; Xu Y; Du W
Surg Laparosc Endosc Percutan Tech; 2019 Dec; 29(6):426-432. PubMed ID: 31490455
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis.
Li X; Tao LP; Wang CH
World J Gastroenterol; 2014 Sep; 20(34):12322-9. PubMed ID: 25232268
[TBL] [Abstract][Full Text] [Related]
36. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis.
Elmunzer BJ; Waljee AK; Elta GH; Taylor JR; Fehmi SM; Higgins PD
Gut; 2008 Sep; 57(9):1262-7. PubMed ID: 18375470
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis.
Zheng M; Bai J; Yuan B; Lin F; You J; Lu M; Gong Y; Chen Y
BMC Gastroenterol; 2008 Feb; 8():6. PubMed ID: 18271973
[TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drugs reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Li L; Han Z; Yuan H; Zhang G; Jia Y; He C
J Hepatobiliary Pancreat Sci; 2017 Sep; 24(9):520-529. PubMed ID: 28681997
[TBL] [Abstract][Full Text] [Related]
39. The effect of indomethacin in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis.
Ahmad D; Lopez KT; Esmadi MA; Oroszi G; Matteson-Kome ML; Choudhary A; Bechtold ML
Pancreas; 2014 Apr; 43(3):338-42. PubMed ID: 24622061
[TBL] [Abstract][Full Text] [Related]
40. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
Testoni PA; Mariani A; Masci E; Curioni S
Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
